• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Pertuzumab

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup
Labeling Sections with
Pharmacogenomic
Information
PertuzumabOncologyERBB2HER2 protein
overexpression positive
Indications and Usage
Warnings and Precautions
Adverse Reactions
Clinical Studies
Clinical Pharmacology

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling